간편하게 보는 뉴스는 유니콘뉴스
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

· 등록일 Dec. 07, 2023 14:30

· 업데이트일 2023-12-07 15:02:49

CAMBRIDGE, MASS.--(Business Wire / Korea Newswire)--ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently served as Chief Executive Officer of CSL and brings over 40 years of leadership experience across the biotechnology industry.

“Paul is a distinguished industry executive recognized for his extensive track record in drug development and was integral to the growth of CSL to become an international leader in the field. His leadership and extensive knowledge of the biotech industry will be an invaluable addition to our company as we continue to build our portfolio of novel RNA medicines,” said Amit D. Munshi, Chief Executive Officer of ReNAgade. “We are pleased to welcome Paul to the ReNAgade team and look forward to his contributions.”

“I am thrilled to join ReNAgade at this exciting time for the company,” said Mr. Perreault. “ReNAgade is led by a world-class executive team, and its innovative technologies have the potential to drive the field of RNA medicines forward on an unprecedented scale in the coming years.”

Mr. Perreault brings more than 40 years of experience in the global biotechnology and pharmaceutical industries, most recently as CEO and Managing Director of CSL. Within his 25-year career with CSL, he was responsible for operations in more than 40 countries, including major manufacturing sites in the U.S., Switzerland, Germany and Australia, and an extensive network of plasma collection centers throughout North America and Germany. He previously served in senior leadership roles at various companies in the space including Wyeth, Centeon, Aventis Bioservices and Aventis Behring, and served on the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA). In 2019, Mr. Perreault was included in Harvard Business Review’s CEO 100 List and recognized as one of the best performing CEOs in the world. He earned his B.S. in Psychology from the University of Central Florida and completed advanced business management training at Kellogg School of Management and Wharton School of the University of Pennsylvania.

About ReNAgade Therapeutics

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.

ReNAgade Therapeutics—RNA Without Limits

For more information about the company, its technologies, and its leadership, visit www.renagadetx.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20231205970464/en/

Website: https://renagadetx.com/ View Korean version of this release Contact ReNAgade Therapeutics
Investor Relations
Argot Partners
Emily Brabbit
(212) 600-1902
[email protected]

Media Relations
Argot Partners
Sarah Sutton
(212) 600-1902
[email protected]
This news is a press release from the provider.
Korea Newswire is committed to verifying the transparency of providers and eliminating content errors.
You can receive press releases from this company or in industries of interest via email and RSS for free. Subscribe> News provided byReNAgade Therapeutics Distribution Channel Health Pharmaceutical Biotechnology Personnel anouncement Overseas
인기 기사04.02 13시 기준
충주--(뉴스와이어)--현대엘리베이터가 지속가능경영 전략과 성과를 담은 ‘2023-24 ESG 보고서’를 공개했다. 2023-24 현대엘리베이터 ESG 보고서 표지 이번 보고서에는 환경·사회·지배구조 분야에서의 다양한 활동이...
인천--(뉴스와이어)--알지팩토리(RGFACTORY)는 1월 4일 인천 의료기관 컬래버레이션 기획을 통해 ‘외국어 관광 가이드 및 코디네이터를 위한 뇌졸중 팸러닝’을 진행, 성공적으로 마무리했다고 밝혔다. 외국어 관광 가이드 및 코디네이터...
제주--(뉴스와이어)--제주한라대학교가 ‘디지털새싹 성과확산 캠프’를 통해 호남·제주 지역 학생들을 대상으로 프로그래밍, 코딩, 앱 개발 등의 IT 교육을 제공했다고 밝혔다. 제주한라대 디지털새싹 성과확산대회, 혁신 아이디어와 참가자들 열정...
서울--(뉴스와이어)--좋은땅출판사가 ‘유비쿼터스 자기 계발과 창의적 변화와 혁신’을 펴냈다. 이정완 지음, 좋은땅출판사, 156쪽, 2만4000원 ‘유비쿼터스 자기 계발과 창의적 변화와 혁신’은 유비쿼터스...
안양--(뉴스와이어)--LS ELECTRIC(일렉트릭)이 2040년까지 재생에너지사용 100% 전환을 선언했다. LS일렉트릭 청주스마트공장 전경 LS일렉트릭이 국내 중전업계 최초로 RE100(재생에너지: Renewable Electricity 100% 사용)에 가입했다고...
서울--(뉴스와이어)--이승만 전 대통령의 청년 시절 행보를 소설로 풀어낸 책이 출간됐다. 바람의 아들 이승만, 김창균 지음, 230쪽, 1만5000원 북랩은 최근 구한말...
API
fg
유니콘뉴스는 보도자료 배포 서비스입니다.
여기에 뉴스를 등록하면 언론이 보도하고 널리 배포됩니다.